Vikas Lifecare Plans ₹200 Crore Capital Infusion

Vikas Lifecare Limited's board of directors met on April 11, 2026, approving a substantial fundraising plan aimed at securing up to ₹200 crore. This capital will be raised through a preferential issue of warrants and/or equity shares. To facilitate this, the company also plans to increase its authorized share capital to ₹300 crore and has initiated updates to its Articles of Association.

Funding Fuels Growth Ambitions

The capital infusion is intended to strengthen Vikas Lifecare's financial position, enabling the company to pursue expansion strategies and explore new avenues for business growth. Increasing authorized share capital is a necessary step before issuing new securities, demonstrating a proactive approach to meeting future funding requirements.

Diversification and Past Deals

Vikas Lifecare, previously known as Vikas Multicorp, has been broadening its business activities beyond its core polymer and chemical sectors. In a significant development, the company finalized a technology transfer agreement in December 2024 with DRDO for eco-friendly biodegradable granules.

Shareholder Approval and Next Steps

Shareholders will need to vote on and approve these corporate actions, including the preferential issue and the proposed increase in authorized share capital. The company will then proceed with identifying and allocating warrants or equity shares to select investors. The funds raised are expected to support strategic growth initiatives and operational enhancements.

Investor Considerations and Risks

The price for the preferential allotment must comply with the Securities and Exchange Board of India's (SEBI) applicable pricing formula. Investors may wish to note the company's past financial performance, including net losses and declining profit margins, which could warrant caution. While SEBI imposed a ₹200,000 penalty in early 2025 for alleged non-disclosure, the company was later cleared of adverse findings in a separate SEBI matter in December 2025.

Peer Group Benchmarks

Vikas Lifecare's diverse business model, which spans chemicals, polymers, agro, and FMCG, makes direct peer comparison challenging. Companies such as Dhampur Bio Organics Ltd, Mangalam Global Ent Ltd, and Kn Agri Resources Limited operate in related sectors and can offer benchmarks for growth strategies and capital deployment.

What to Watch Next

Investors will be monitoring the finalization of the preferential issue details, including the specific price and the selected allottees. Tracking subsequent regulatory filings for shareholder approvals, the completion of the fundraising process, and observing how the company deploys the newly raised capital towards its stated growth objectives will be key.